IMAP France advises Biogroup on its acquisition of Oriade-Noviale group
Biogroup continued its development in France thanks to its merger with Oriade-Noviale/GLBM, a major player in medical biology in the Auvergne-Rhône-Alpes region.
Oriade-Noviale/GLBM, a group owned by its biologists, is positioned as a major player in medical biology in the Auvergne-Rhône-Alpes region. Operating 55 laboratories as well as 4 technical platforms, mainly in the departments of Isère, Loire and Haute-Savoie, Oriade-Noviale/GLBM achieved a turnover of approximately €100 million in 2019.
Vi hoppas få höra ifrån dig. Vårt team finns alltid tillgängliga.
Kontaktformulär
Vad spännande att du vill höra mer kring IMAP. Använd gärna formuläret nedan för att berätta lite mer om din nuvarande situation så lovar vi att återkomma så snart som möjligt.